BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2996584)

  • 41. Kinetics of ubiquinone reduction by the resolved succinate: ubiquinone reductase.
    Grivennikova VG; Vinogradov AD
    Biochim Biophys Acta; 1982 Dec; 682(3):491-5. PubMed ID: 7150582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Participation of tocopherol and its analogs in lipid peroxidation processes and electron transport in rat liver mitochondria in vivo].
    Kunitsa NI; Kuz'menko IV; Alekseev SM; Zakharova EI; Donchenko GV
    Biokhimiia; 1993 Nov; 58(11):1709-13. PubMed ID: 8268310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental observations on the structure and function of mitochondrial complex III that are unresolved by the protonmotive ubiquinone-cycle hypothesis.
    Rieske JS
    J Bioenerg Biomembr; 1986 Jun; 18(3):235-57. PubMed ID: 3015898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modification of the catalytic function of the mitochondrial cytochrome b-c1 complex by dicyclohexylcarbodiimide.
    Degli Esposti M; Meier EM; Timoneda J; Lenaz G
    Biochim Biophys Acta; 1983 Nov; 725(2):349-60. PubMed ID: 6315061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein-ubiquinone interaction: synthesis and biological properties of ethoxy ubiquinone derivatives.
    He DY; Gu LQ; Yu L; Yu CA
    Biochemistry; 1994 Feb; 33(4):880-4. PubMed ID: 8305435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction between succinate dehydrogenase and ubiquinone-binding protein from succinate-ubiquinone reductase.
    Yu L; Yu CA
    Biochim Biophys Acta; 1980 Nov; 593(1):24-38. PubMed ID: 7426645
    [No Abstract]   [Full Text] [Related]  

  • 47. Interaction of ubiquinone and vitamin K3 with mitochondrial succinate-ubiquinone oxidoreductase.
    Kotlyar AB; Gutman M; Ackrell BA
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1656-62. PubMed ID: 1510689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Atpenins, potent and specific inhibitors of mitochondrial complex II (succinate-ubiquinone oxidoreductase).
    Miyadera H; Shiomi K; Ui H; Yamaguchi Y; Masuma R; Tomoda H; Miyoshi H; Osanai A; Kita K; Omura S
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):473-7. PubMed ID: 12515859
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion.
    Hargreaves P; Rahman S; Guthrie P; Taanman JW; Leonard JV; Land JM; Heales SJ
    J Inherit Metab Dis; 2002 Feb; 25(1):7-16. PubMed ID: 12004863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.
    Shults CW; Haas RH; Passov D; Beal MF
    Ann Neurol; 1997 Aug; 42(2):261-4. PubMed ID: 9266740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific interaction between protein and ubiquinone in succinate-ubiquinone reductase.
    Yu CA; Yu L
    J Biol Chem; 1982 Jun; 257(11):6127-31. PubMed ID: 7076666
    [No Abstract]   [Full Text] [Related]  

  • 52. Mitochondrial ubiquinol oxidation is necessary for tumour growth.
    Martínez-Reyes I; Cardona LR; Kong H; Vasan K; McElroy GS; Werner M; Kihshen H; Reczek CR; Weinberg SE; Gao P; Steinert EM; Piseaux R; Budinger GRS; Chandel NS
    Nature; 2020 Sep; 585(7824):288-292. PubMed ID: 32641834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and biological activity of derivatives of ubiquinone: photoaffinity analogues containing the 4-azido-2-nitroanilino group.
    Campbell HD; Rogers BL; Young IG
    Biochemistry; 1986 Jan; 25(1):172-7. PubMed ID: 3082354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fumarate reductase activity of bovine heart succinate-ubiquinone reductase. New assay system and overall properties of the reaction.
    Grivennikova VG; Gavrikova EV; Timoshin AA; Vinogradov AD
    Biochim Biophys Acta; 1993 Jan; 1140(3):282-92. PubMed ID: 8417779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Malate oxidation by mitochondrial succinate:ubiquinone-reductase].
    Belikova IuO; Kotliar AB
    Biokhimiia; 1988 Apr; 53(4):668-76. PubMed ID: 3395646
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential investigation of the capacity of succinate oxidation in human skeletal muscle.
    Fischer JC; Ruitenbeek W; Berden JA; Trijbels JM; Veerkamp JH; Stadhouders AM; Sengers RC; Janssen AJ
    Clin Chim Acta; 1985 Nov; 153(1):23-36. PubMed ID: 3000647
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of the ubiquinone-binding domain in QPs1 of succinate-ubiquinone reductase.
    Lee GY; He DY; Yu L; Yu CA
    J Biol Chem; 1995 Mar; 270(11):6193-8. PubMed ID: 7890754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The distal heme center in Bacillus subtilis succinate:quinone reductase is crucial for electron transfer to menaquinone.
    Matsson M; Tolstoy D; Aasa R; Hederstedt L
    Biochemistry; 2000 Jul; 39(29):8617-24. PubMed ID: 10913269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats.
    Krähenbühl S; Talos C; Lauterburg BH; Reichen J
    Hepatology; 1995 Aug; 22(2):607-12. PubMed ID: 7635430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bypasses of the antimycin a block of mitochondrial electron transport in relation to ubisemiquinone function.
    Alexandre A; Lehninger AL
    Biochim Biophys Acta; 1984 Oct; 767(1):120-9. PubMed ID: 6091750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.